Information ⬇
Editors
Eosinophilic Pneumonia
Essentials
- In clinical work, eosinophilic pneumonias are a heterogeneous group of diseases characterized by pulmonary eosinophilia, pulmonary infiltrates and/or pulmonary dysfunction and often blood eosinophilia.
- Eosinophilic pneumonias may be idiopathic or associated with other disorders or other known factors.
- Clinically, the disease may be chronic or acute and even life-threatening.
- Think of the possibility of eosinophilic pneumonia in a patient with pneumonia
- not responding to treatment
- associated with eosinophilia
- with systemic symptoms, such as cardiac symptoms or a rash.
Classification
- Eosinophilic pneumonias can be classified into
- idiopathic
- secondary
- associated with other disorders.
Symptoms
- Cough, sharp chest pain, dyspnoea
- Fever
- In chronic forms of the disease also weight loss and fatigue
Idiopathic eosinophilic pneumonia
Acute idiopathic eosinophilic pneumonia
- Symptoms develop in a few days in an originally healthy young adult.
- May be associated with changes in smoking habits but one patient in three is non-smoking.
- May also develop after various kinds of respiratory exposure (smoke or fumes, soil (plant-repotting), dust (household renovation), etc.).
- One or more patchy infiltrates on chest x-ray, and possibly pleural effusion.
- Leukocytosis but not necessarily eosinophilia
- Often hypoxaemia
- The diagnosis can be confirmed by high-resolution computed tomography of the lungs and bronchoscopy with bronchoalveolar lavage (BAL).
- Glucocorticoids (e.g. 1 to 2 mg/kg/day prednisolone for 6 to 8 weeks, gradually reducing the dose) give a rapid response.
- No relapses.
Chronic idiopathic eosinophilic pneumonia
- Symptoms develop slowly, within several weeks or months.
- The disease is often preceded by asthma and chronic sinus problems.
- Chest x-ray shows one or more peripheral patchy infiltrates that may shift position.
- Elevated CRP and ESR, often also IgE, neutrophilia, anaemia, often eosinophilia
- The diagnosis can be confirmed by high-resolution computed tomography of the lungs and bronchoscopy with bronchoalveolar lavage (BAL).
- Glucocorticoid treatment (e.g. prednisolone) at a dosage of 0.5 mg/kg often leads to resolution of the changes in the chest x-ray within as little as a week. Treatment with decreasing doses should be continued for 6 to 12 months.
- More than half of the patients have relapses.
Hypereosinophilic syndrome
- Blood eosinophil levels repeatedly exceeding 1.5 × 109 /l and clinically significant organ damage
- The most common target organs in addition to the lungs are:
- heart: arrhythmias, cardiac failure, valve disease, pericarditis, thromboembolism
- nervous system: peripheral nerve damage, neuropathic pain, hemiplegia
- skin: various types of rash.
- May be due to drugs, parasites, mycobacterial infection, fungi (allergic bronchopulmonary aspergillosis), radiotherapy or toxic agents (e.g. inhaled illegal drugs).
- The symptoms of drug reaction may begin within a few hours but, most commonly, within several weeks or months after the beginning of medication.
- The delay between the eosinophilic manifestation caused by some parasites and the original infection may be months or years. A careful travel history is always necessary when investigating eosinophilia.
- Patchy lesions are commonly seen in the chest x-ray; pleural effusion may also be present.
- Treatment depends on the aetiology. If a drug reaction is suspected, withdrawal of the medication is the primary form of treatment.
- If symptoms are severe, glucocorticoids may be indicated.
- In parasitic diseases the specific treatment is selected on the basis of the causative agent. Consulting a specialist in infectious diseases is advisable.
Eosinophilic pneumonia associated with other diseases
Eosinophilic granulomatosis with polyangitis (Churg-Strauss)
- See Vasculitides Vasculitides.
- Patients often have severe asthma and allergic rhinitis. Extrapulmonary manifestations of the disease often lead to the right diagnostic track.
- Tissue biopsy specimens show eosinophilic arteritis and granulomas.
- ANCA antibodies (antineutrophil cytoplasmic antibodies) are positive in 40% of patients.
- Oral glucocorticoids should be used primarily.
Connective tissue diseases and malignancies
- If the response to glucocorticoids is poor, the possibility of malignancy should be kept in mind.
- Examinations: clinical examination, mammography, gynaecological examination; CT should be considered.
References
- Camus P. Drug-induced respiratory disease website: www.pneumotox.com http://www.pneumotox.com/
- Cottin V. Eosinophilic Lung Diseases. Clin Chest Med 2016;37(3):535-56. [PubMed]
- Allen J, Wert M. Eosinophilic Pneumonias. J Allergy Clin Immunol Pract 2018;6(5):1455-1461. [PubMed]
- De Giacomi F, Vassallo R, Yi ES ym. Acute Eosinophilic Pneumonia. Causes, Diagnosis, and Management. Am J Respir Crit Care Med 2018;197(6):728-736. [PubMed]
Evidence Summaries ⬆